British Heart Foundation PROTECT-TAVI: New Clinical Insights
Boston Scientific's Interventional Cardiology Therapies CMO, Dr.Janar Sathananthan, is joined by Prof. Rajesh Kharbanda, Dr.Samir Kapadia, and Dr. Michael Rinaldi to discuss the latest clinical data from the British Heart Foundation P-TAVI trial. In this insightful discussion they analyze the data, offering expert perspectives on how these findings may influence current treatment approaches and patient outcomes. They also explore the role of the upcoming BHF P-TAVI/PTAVR meta-analysis in shaping the future of TAVI.
Comments 0
Login to view comments.
Click here to Login
